After months of dismissal, Shoker learned his symptoms were stage 4 Hodgkin lymphoma. Now he’s sharing his journey and hope ...

You will likely not get mono twice, as once you have the virus that causes mono, it will usually remain inactive in your body ...

NRIX stock is rated Strong Buy as bexobrutideg advances in CLL trials. See here for NRIX stock's milestones, market potential ...

Several pharmaceutical companies showcased data on their BTK inhibitors at the ASCO 2023 conference, including Ono ...

The best immune boosting foods contain critical nutrients like vitamin C and A ...

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...

AstraZeneca's blood cancer treatment, Calquence, failed to improve survival rates and prevent lung failure in patients hospitalised with symptoms of COVID-19, the drugmaker said on Thursday, citing ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

Are you preparing for UPSC CSE Prelims 2026? Check your progress and revise your topics through this quiz on Science and ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...

Lymphoma is one of the most common blood cancers worldwide. While there are no exact statistics for Cayman, the global burden of lymphoma makes early detection essential for better outcomes.